Inhibitors of dihydrofolate reductase in leishmania and trypanosomes

    Research output: Contribution to journalArticlepeer-review

    107 Citations (Scopus)


    The protozoan diseases leishmaniasis, Chagas' disease and African trypanosomiasis are major health problems in many countries, particularly developing countries, and there are few drugs available to treat these diseases. Dihydrofolate reductase (DHFR) inhibitors have been used successfully in the treatment of a number of other diseases such as cancer, malaria and bacterial infections; however they have not been used for the treatment of these diseases. This article summarises studies on leishmanial and trypanosomal DHFR inhibitor development and evaluation. Possible mechanisms of resistance to DHFR inhibitors are also discussed. (C) 2002 Elsevier Science B.V All rights reserved.

    Original languageEnglish
    Pages (from-to)249-257
    Number of pages9
    JournalBBA - Molecular Basis of Disease
    Issue number2-3
    Publication statusPublished - 18 Jul 2002


    Dive into the research topics of 'Inhibitors of dihydrofolate reductase in leishmania and trypanosomes'. Together they form a unique fingerprint.

    Cite this